This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Cryolife, Inc.. Active years: 2002-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2010
Title: Innovations by Jeremy D. Ollerenshaw in Tissue Grafting
Introduction
Jeremy D. Ollerenshaw is an accomplished inventor based in Marietta, GA, USA. He has made significant contributions to the field of tissue grafting, holding four patents that reflect his innovative approach to medical technology. Through his work, Ollerenshaw aims to improve the efficacy and availability of tissue graft materials for clinical use.
Latest Patents
Among his latest patents, Ollerenshaw has developed a groundbreaking tissue graft material that addresses the needs for both vascular and non-vascular tissue replacements. The invention focuses on a method of preparing this multipurpose tissue graft material, paving the way for enhanced medical applications and providing solutions for challenging surgical procedures.
Career Highlights
Jeremy D. Ollerenshaw currently works for Cryolife, Inc., a company renowned for its advancements in the field of regenerative medicine. His role at Cryolife has enabled him to collaborate with leading experts and researchers in the area of tissue engineering, further enhancing his contributions to medical science.
Collaborations
Throughout his career, Ollerenshaw has worked alongside respected colleagues such as Kirby S. Black and Umit Yuksel. These collaborations have fostered a rich exchange of ideas, contributing to the successful development of innovative solutions in tissue grafting.
Conclusion
With a strong foundation in medical innovation, Jeremy D. Ollerenshaw continues to make strides in the development of tissue graft materials. His patents not only showcase his technical expertise but also reflect a commitment to improving patient outcomes through advanced medical technologies. Ollerenshaw’s work at Cryolife, Inc. and his fruitful collaborations underscore the importance of innovation in the evolving landscape of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
